| Code | 06621 | ||||||||||
| MA number | EU/1/11/676/001 | ||||||||||
| Product Form: | cif fol 1x1,5 ml/60 mg konc. + 1x4,5 ml solv. (liek.inj.skl.) | ||||||||||
| MA Status: | E - Valid centralised marketing authorisation | ||||||||||
| Type of procedure: | EU | ||||||||||
| MAH, country: | Sanofi Winthrop Industrie, France | ||||||||||
| Therapeutic Class: | 44 - CYTOSTATICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | glass vial | ||||||||||
| Route of admin.: | Intravenous use |
| Prescription Status: | Medicinal product subject to restricted medical prescription. |
| Legal basis: | Article 8(3) application - new active substance |
| MA issued: | 17.03.2011 |
| SmPC + PL: |
European Medicines Agency's database
|
| Dokument: |
DHCP_Jevtana 7 11 2013.pdf
|
| Safety feature | Yes |
| Data update: | 30.12.2020 |
